Tetrathiomolybdate Protects against Bile Duct Ligation-Induced Cholestatic Liver Injury and Fibrosis

Tetrathiomolybdate (TM), a potent copper-chelating drug, was initially developed for the treatment of Wilson’s disease. Our working hypothesis is that the fibrotic pathway is copper-dependent. Because biliary excretion is the major pathway for copper elimination, a bile duct ligation (BDL) mouse mod...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Pharmacol Exp Ther
Main Authors: Song, Ming, Song, Zhenyuan, Barve, Shirish, Zhang, Jingwen, Chen, Theresa, Liu, Marcia, Arteel, Gavin E., Brewer, George J., McClain, Craig J.
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4222180/
https://ncbi.nlm.nih.gov/pubmed/18299419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.107.131227
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki